Position Statements PDF Print E-mail

iPAG

IPAG would like to see all patients with Type 1 diabetes in Scotland who could benefit from insulin pump therapy have access to this therapy in accordance with SIGN guidance 116 and NICE TA 151.

Insulin pump therapy should be available as part of a comprehensive diabetes support service and not on the basis of where you live in Scotland or your ability to self-fund.

Patient suitability should be assessed on the basis of clinical need and patient choice. Those patients who meet the criteria should be offered a choice of pump and should have unrestricted access to test strips in line with the recommendation of their clinical team.

We also support the increasing use of Continuous Glucose Monitors to aid personal management by improving knowledge of blood glucose changes on a day to day basis. Thereby improving personal control and quality of life.

JDRF

Diabetes UK

Insulin pump therapy should be offered as a treatment for diabetes to children, young persons and adults with Type 1 diabetes as part of a cohesive and comprehensive diabetes service. Appropriateness should be determined by clinical need, personal choice and suitability - not on the basis of where a person lives or ability to pay.

The Association of British Clinical Diabetologists

NHS QIS

In regard to NICE TA151 NHS QIS state that - NHS Scotland should note that:

1. No important differences were identified for this NICE appraisal and NHS Quality Improvement Scotland advises that the recommendations are as valid for Scotland as for England and Wales.

The Medical Technology Group

American Association of Clinical Endocrinologists 

Consensus Panel on Insulin Pump Management

Support for pumps by Dr Rowan Hillson MBE, National Clinical Director for Diabetes in England. Read article here


Add this to your website
e-max.it: your social media marketing partner